Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 12 save search
Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1 as a Novel Checkpoint on the DNAM Axis at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -10.51%
H: 0.0%
C: 0.0%
pvrig
Apellis Reiterates Plans to Submit a New Drug Application in the First Half of 2022 for Pegcetacoplan for Geographic Atrophy Following FDA Feedback
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
APLS | $47.0 -1.07% 480K
|
Health Technology
|
| O: 7.31%
H: 5.57%
C: 4.02%
new drug fda application drug
Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
SRRK A | $13.65 -2.15% 240K
|
Health Technology
|
| O: -0.35%
H: 3.45%
C: 2.09%
treatment solid tumors phase 1 therapy trial
Oncorus Reports Initial Safety, Tolerability, Immune Activation and Positive Clinical Response Data from its Ongoing Phase 1 Clinical Study of ONCR-177, its Lead Viral Immunotherapy Candidate, at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -35.41%
H: 1.67%
C: -15.76%
immunotherapy ongoing phase 1 positive therapy
Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
JSPR | $22.31 -3.88% 32K
|
|
| O: -0.36%
H: 4.43%
C: 1.44%
AVRO | $1.225 -1.21% 3.9K
|
Health Technology
|
| O: 0.37%
H: 8.41%
C: -0.93%
financial results results
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
AGE A | $11.1 0.0% 3.8K
|
Health Technology
|
| O: -2.27%
H: 2.49%
C: 1.25%
financial results results therapeutics
Humanigen Reports Third Quarter and Nine Months Ending September 30, 2021 Financial Results and Provides Corporate Update
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.48%
H: 1.11%
C: 0.16%
financial results results
International Paper Announces Price Determination with Respect to Cash Tender Offer for Certain of its Outstanding Notes for up to $500 Million Combined Aggregate Principal Amount
Published: 2021-11-12 (Crawled : 23:00) - prnewswire.com
IP | News S | $35.295 0.1% 10M
|
Process Industries
| Email alert
Add to watchlist
Aurora Cannabis Announces Results of 2021 Annual General Meeting
Published: 2021-11-12 (Crawled : 23:00) - prnewswire.com
ACB | $6.63 1.45% 4.5M
|
Process Industries
| Email alert
Add to watchlist
results cannabis
Milind K. Ambe is being recognized by Continental Who's Who
Published: 2021-11-12 (Crawled : 23:00) - prnewswire.com
FNCTF | News | $11.0354 320
|
Communications
| Email alert
Add to watchlist
Industry Merger Creates Powerful New Digital Signage Leader
Published: 2021-11-12 (Crawled : 23:00) - prnewswire.com
CREX | $3.0 -3.54% 71K
|
Technology Services
| Email alert
Add to watchlist
merge
The key to reducing no-shows: Empower your Patients
Published: 2021-11-12 (Crawled : 23:00) - phreesia.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial Results
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ROIV | $10.305 -0.53% 1.7M
|
Manufacturing
|
| O: -0.38%
H: 9.11%
C: 7.83%
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: -4.48%
H: 4.17%
C: 3.65%
financial results gene therapies results therapy gene therapy
Replimune Provides Updated Data from RP2 at the 2021 Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
REPL | $6.56 -5.88% 310K
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer
Xilio Therapeutics Announces Preclinical Data Demonstrating Anti-Tumor Activity and Tolerability of XTX301, a Tumor-Selective IL-12, at Society for Immunotherapy in Cancer Annual Meeting
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
XLO | $1.24 -3.13% 90K
|
Professional, Scientific, and T...
|
| O: -3.14%
H: 0.07%
C: -3.67%
preclinical immunotherapy therapy cancer pre-clinical
Second Genome Presents Preclinical Data at SITC 2021 Demonstrating that a CXCR3-Positive Allosteric Modulator, SG-3-00802, Targets a Key Mechanism Required for Efficacious Immunotherapy
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
GILD | News | $66.33 0.26% 2.8M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
preclinical immunotherapy positive therapy pre-clinical
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ACET | $1.915 -5.43% 270K
|
Health Technology
|
| O: 0.84%
H: 2.28%
C: 0.93%
preclinical solid tumors adi-001 pre-clinical gpt-3
Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 with Opdivo® and BMS-986207 (Anti-TIGIT Antibody) at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: -1.06%
H: 0.0%
C: 0.0%
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -10.51%
H: 0.0%
C: 0.0%
phase 1 results antibody
BMT Monday Market Insights – November 15, 2021
Published: 2021-11-12 (Crawled : 23:00) - bmt.com
WSFS F | $42.81 2.29% 71K
|
Finance
|
| O: 0.31%
H: 0.0%
C: 0.0%
market
Third Coast Bancshares, Inc. Announces Closing of Upsized Initial Public Offering of Common Stock
Published: 2021-11-12 (Crawled : 22:00) - feed.businesswire.com
TCBX | $18.825 1.48% 4.8K
|
| Email alert
Add to watchlist
offering
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
CHRO | $1.53 24.9% 100K
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.